Peapack Gladstone Financial Corp Johnson & Johnson Transaction History

Peapack Gladstone Financial Corp

$6.51 Billion
Q2 2024

A detailed history of Peapack Gladstone Financial Corp transactions in Johnson & Johnson stock. As of the latest transaction made, Peapack Gladstone Financial Corp holds 448,653 shares of JNJ stock, worth $68.7 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares

448,653

Previous 463,494 3.2%

Holding current value

$68.7 Million

Previous $73.3 Million 10.56%

% of portfolio

1.01%

Previous 1.15%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$144.38 - $157.78 $2.14 Million - $2.34 Million	-14,841 Reduced 3.2%	448,653 $65.6 Million
Q1 2024 May 10, 2024	SELL	$155.22 - $162.74 $831,513 - $871,798	-5,357 Reduced 1.14%	463,494 $73.3 Million
Q4 2023 Feb 13, 2024	SELL	$145.6 - $158.88 $716,934 - $782,325	-4,924 Reduced 1.04%	468,851 $73.5 Million
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $334,706 - $374,957	-2,149 Reduced 0.45%	473,775 $73.8 Million
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $232,296 - $249,995	1,505 Added 0.32%	475,924 $78.8 Million
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $1.45 Million - $1.73 Million	-9,611 Reduced 1.99%	474,419 $75.6 Million
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $1.71 Million - $1.92 Million	-10,684 Reduced 2.16%	484,030 $85.5 Million
Q3 2022 Nov 10, 2022	BUY	$161.33 - $179.52 $14.4 Million - $16.1 Million	89,435 Added 22.07%	494,714 $80.8 Million
Q2 2022 Aug 12, 2022	SELL	$168.19 - $186.01 $841,622 - $930,794	-5,004 Reduced 1.22%	405,279 $71.9 Million
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $130,307 - $147,982	-824 Reduced 0.2%	410,283 $72.9 Million
Q4 2021 Feb 15, 2022	BUY	$155.93 - $173.01 $98,391 - $109,169	631 Added 0.15%	411,107 $70.3 Million
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $9.98 Million - $11.1 Million	61,781 Added 17.72%	410,476 $66.3 Million
Q2 2021 Aug 16, 2021	SELL	$159.48 - $171.07 $310,029 - $332,560	-1,944 Reduced 0.55%	348,695 $57.4 Million
Q1 2021 May 14, 2021	BUY	$153.07 - $170.48 $2.35 Million - $2.62 Million	15,352 Added 4.58%	350,639 $57.6 Million
Q4 2020 Feb 16, 2021	SELL	$137.11 - $157.38 $3.76 Million - $4.32 Million	-27,457 Reduced 7.57%	335,287 $52.8 Million
Q3 2020 Nov 16, 2020	BUY	$140.38 - $153.83 $93,071 - $101,989	663 Added 0.18%	362,744 $54 Million
Q2 2020 Aug 14, 2020	BUY	$128.81 - $155.51 $46,242 - $55,828	359 Added 0.1%	362,081 $50.9 Million
Q1 2020 May 15, 2020	SELL	$111.14 - $153.99 $487,126 - $674,938	-4,383 Reduced 1.2%	361,722 $47.4 Million
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $933,555 - $1.07 Million	-7,322 Reduced 1.96%	366,105 $53.4 Million
Q3 2019 Nov 13, 2019	SELL	$126.95 - $142.14 $486,980 - $545,249	-3,836 Reduced 1.02%	373,427 $48.3 Million
Q2 2019 Aug 15, 2019	BUY	$131.15 - $144.24 $629,520 - $692,352	4,800 Added 1.29%	377,263 $52.5 Million
Q1 2019 May 15, 2019	BUY	$125.72 - $139.79 $143,697 - $159,779	1,143 Added 0.31%	372,463 $52.1 Million
Q4 2018 Feb 14, 2019	BUY	$122.84 - $147.84 $12.1 Million - $14.5 Million	98,112 Added 35.91%	371,320 $47.9 Million
Q3 2018 Nov 14, 2018	SELL	$121.58 - $142.88 $11,671 - $13,716	-96 Reduced 0.04%	273,208 $37.7 Million
Q2 2018 Aug 09, 2018	BUY	$119.4 - $131.76 $1.31 Million - $1.45 Million	11,007 Added 4.2%	273,304 $33.2 Million
Q1 2018 May 10, 2018	SELL	$125.1 - $148.14 $253,827 - $300,576	-2,029 Reduced 0.77%	262,297 $0
Q4 2017 Feb 14, 2018	SELL	$131.22 - $143.62 $487,875 - $533,979	-3,718 Reduced 1.39%	264,326 $0
Q3 2017 Nov 14, 2017	SELL	$129.47 - $135.38 $580,155 - $606,637	-4,481 Reduced 1.64%	268,044 $0
Q2 2017 Aug 14, 2017	BUY	N/A	272,525	272,525 $0

Others Institutions Holding JNJ

# of Institutions

4,270

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $400B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peapack Gladstone Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Peapack Gladstone Financial Corp with notifications on news.

Account

Peapack Gladstone Financial Corp Johnson & Johnson Transaction History